Use of hymenialdisine or derivatives thereof in the manufacture of medicaments

摘要

The invention relates to the use of hymenialdisine or derivatives thereof of formula I in which R<1> and R<2>, identical or different, represent H or Br, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in inhibiting cyclin dependent kinases, GSK-3 beta and casein kinase 1. Application for preventing and treating neurodegenerative disorders such as Alzheimer's disease, diabetes, inflammatory pathologies and cancers.